Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-061766
Filing Date
2017-11-20
Accepted
2017-11-20 16:24:35
Documents
1
Period of Report
2017-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2891
  Complete submission text file 0001209191-17-061766.txt   4241
Mailing Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451 781-819-5704
Arsanis, Inc. (Issuer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5425 WISCONSIN AVENUE, SUITE 800 CHEVY CHASE MD 20815
Business Address
Florence Anthony A. Jr. (Reporting) CIK: 0001559827 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 171214041